Found 56 matching trials
Adjuvant FEC Versus EP in Breast Cancer (MIG5) PHASE3 In this multicenter, randomized phase III trial, node positive early breast...
Show More Location
Federico Castiglione
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) PHASE3 This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Treatment of Breast Cancer N/A Observational investigation of participants who are given neoadjuvant treat...
Show More Location
National Institute of Oncolgy
Learn More & Join Trial
Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer PHASE1 Primary Objectives:
* Determine the impact of each regimen on the disease ...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) PHASE3 Researchers are looking for new ways to treat types of breast cancer that a...
Show More Location
Banner MD Anderson Cancer Center ( Site 0066)
Learn More & Join Trial
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer PHASE3 The purpose of this study is to evaluate the addition of Herceptin to stand...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003) PHASE2 Researchers want to learn if giving boserolimab (MK-5890) with standard tre...
Show More Location
Optum Care Cancer Center ( Site 0004)
Learn More & Join Trial
Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast Cancer PHASE2 The main purpose of this study is to confirm the high pathologic complete r...
Show More Location
Istituto Nazionale per La Ricerca sul Cancro (IST)
Learn More & Join Trial
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer PHASE3 The purpose of this study is to assess the efficacy of neoadjuvant weekly n...
Show More Location
Royal Adelaide Hospital
Learn More & Join Trial
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery PHASE3 RATIONALE: Chemotherapy may cause early menopause in premenopausal women. T...
Show More Learn More & Join Trial